# US 2008/0287630 A1 · Endosomolytic Poly(Acrylate) Polymers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0287630 A1
- Document ID: US20080287630A1
- Status: Published application
- Kind: A1
- Application number: 12/140,703
- Filed: 2008-06-17
- Published: 2008-11-20
- Earliest claimed: 2006-08-18
- Assignees: Roche Madison Inc.
- Inventors: Darren H. Wakefield; David B. Rozema; Sean D. Monahan; Lori Higgs; Jon A. Wolff; James E. Hagstrom
- Web page: https://patentgrep.com/patent/US20080287630A1

## CPC

- C12N 15/87: Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- A61K 47/58: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A01K 2217/058: due to expression of inhibitory nucleic acid, e.g. siRNA, antisense
- A01K 2267/0362: Animal model for lipid/glucose metabolism, e.g. obesity, type-2 diabetes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

The present invention is directed to membrane active polymers useful for cellular delivery of compounds. Described are polyconjugates systems that incorporate targeting, anti-opsonization, anti-aggregation, and transfection activities into small biocompatible in vivo delivery conjugates. The use of reversible modification provides for physiologically responsive activity modulation.

## Claims

### Claim 1

A membrane active random poly(acrylate) comprising: a plurality of amine-containing monomers, a plurality of first hydrophobic monomers, and a plurality of second hydrophobic monomers wherein said first and second hydrophobic monomers are different.

### Claim 2 (depends on 1)

The membrane active poly(acrylate) of claim 1 wherein said first and second hydrophobic monomers contain hydrophobic groups selected from the list consisting of:
alkyl group, alkenyl group, alkynyl group, aryl group, aralkyl group, aralkenyl group, and aralkynyl group, each of which may be linear, branched, or cyclic and may can contain one or more substitutions or heteroatoms, sterol, steroid, and steroid derivative.

### Claim 3 (depends on 2)

The membrane active poly(acrylate) of claim 2 wherein said first hydrophobic monomer contain of lower hydrophobic groups and said second hydrophobic groups contain higher hydrophobic groups.

### Claim 4 (depends on 3)

The membrane active poly(acrylate) of claim 3 wherein said first hydrophobic monomers contain butyl groups and said second hydrophobic monomers contain octadecyl groups.

### Claim 5 (depends on 3)

The membrane active poly(acrylate) of claim 3 wherein the amine monomers, first hydrophobic monomers and second hydrophobic monomers are present in about a 6:3:1 ratio.

### Claim 6 (depends on 1)

The membrane active poly(acrylate) of claim 1 wherein the poly(acrylate) further comprises one or more third hydrophobic monomers wherein said third hydrophobic monomers are different from said first and second hydrophobic monomers.

### Claim 7 (depends on 6)

The membrane active poly(acrylate) of claim 6 wherein said third hydrophobic monomers contain hydrophobic groups selected from the group consisting of: aryl group, aralkyl group, aralkenyl group, aralkynyl group, sterol, steroid, and steroid derivative.

### Claim 8 (depends on 1)

The membrane active poly(acrylate) of claim 1 wherein the poly(acrylate) further comprises one or more monomers containing reactive groups suitable for post synthetic modification.

### Claim 9 (depends on 8)

The membrane active poly(acrylate) of claim 8 wherein the reactive groups are selected from the group consisting of: thioester, pyridyldisulfide, and allyne.

### Claim 10 (depends on 1)

The membrane active poly(acrylate) of claim 1 wherein the poly(acrylate) further comprises one or more monomers containing steric stabilizers.

### Claim 11 (depends on 8)

The membrane active poly(acrylate) of claim 8 wherein the steric stabilizers comprise poly(ethylene glycol) groups.

### Claim 12 (depends on 1)

The membrane active poly(acrylate) of claim 1 wherein the poly(acrylate) further comprises one or more monomers containing targeting groups.

### Claim 13 (depends on 12)

The membrane active poly(acrylate) of claim 12 wherein the targeting groups are selected from the group consisting of: cell receptor ligand, saccharide, galactose, galactose derivative, mannose, mannose derivative, aptamer, folate, biotin, vitamin, vitamin A, vitamin D, peptide, and Arg-Gly-Asp (RGD)-containing peptide.

### Claim 14

A reversibly masked membrane active random poly(acrylate) comprising: a plurality of amine-containing monomers, a plurality of first hydrophobic monomers, and a plurality of second hydrophobic monomers wherein said first and second hydrophobic monomers are different and wherein one or more amines of the amine-containing monomers are linked to masking agents via physiologically labile bonds thereby inhibiting membrane activity of the membrane active random poly(acrylate).

### Claim 15 (depends on 14)

The reversibly masked membrane random poly(acrylate) of claim 14 wherein said first and second hydrophobic monomers contain hydrophobic groups selected from the list consisting of: alkyl group, alkenyl group, alkynyl group, aryl group, aralkyl group, aralkenyl group, and aralkynyl group, each of which may be linear, branched, or cyclic and may can contain one or more substitutions or heteroatoms, sterol, steroid, and steroid derivative.

### Claim 16 (depends on 15)

The reversibly masked membrane active random poly(acrylate) of claim 15 wherein said first hydrophobic monomer contain of lower hydrophobic groups and said second hydrophobic groups contain higher hydrophobic groups.

### Claim 17 (depends on 16)

The reversibly masked membrane active random poly(acrylate) of claim 16 wherein said first hydrophobic monomers contain butyl groups and said second hydrophobic monomers contain octadecyl groups.

### Claim 18 (depends on 16)

The reversibly masked membrane active random poly(acrylate) of claim 16 wherein the amine monomers, first hydrophobic monomers and second hydrophobic monomers are present in a 6:3:1 ratio.

### Claim 19 (depends on 14)

The reversibly masked membrane active random poly(acrylate) of claim 14 wherein the poly(acrylate) further comprises one or more third hydrophobic monomers wherein said third hydrophobic monomers are different from said first and second hydrophobic monomers.

### Claim 20 (depends on 19)

The reversibly masked membrane active random poly(acrylate) of claim 19 wherein said third hydrophobic monomers contain hydrophobic groups selected from the group consisting of: aryl group, aralkyl group, aralkenyl group, aralkynyl group, sterol, steroid, and steroid derivative.

### Claim 21 (depends on 14)

The reversibly masked membrane active random poly(acrylate) of claim 14 wherein the poly(acrylate) further comprises one or more monomers containing reactive groups suitable for post synthetic modification.

### Claim 22 (depends on 21)

The reversibly masked membrane active random poly(acrylate) of claim 21 wherein the reactive groups are selected from the group consisting of: thioester, pyridyldisulfide, and allyne.

### Claim 23 (depends on 14)

The reversibly masked membrane active random poly(acrylate) of claim 14 wherein the poly(acrylate) further comprises one or more monomers containing steric atabilizers.

### Claim 24 (depends on 23)

The reversibly masked membrane active random poly(acrylate) of claim 23 wherein the steric stabilizers comprise poly(ethylene glycol) groups.

### Claim 25 (depends on 14)

The reversibly masked membrane active random poly(acrylate) of claim 14 wherein the poly(acrylate) further comprises one or more monomers containing targeting groups.

### Claim 26 (depends on 25)

The reversibly masked membrane active random poly(acrylate) of claim 25 wherein the targeting groups are selected from the group consisting of: cell receptor ligand, saccharide, galactose, galactose derivative, mannose, mannose derivative, aptamers, folate, biotin, vitamin A, vitamin D, peptide, and Arg-Gly-Asp (RGD)-containing peptide.

### Claim 27 (depends on 14)

The reversibly masked membrane active random poly(acrylate) of claim 14 wherein said masking agents are selected from the group consisting of: targeting groups, steric stabilizers, charge modifiers, and combinations of targeting groups, steric stabilizers, and charge modifiers.
